Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Many households succeed with zero based budgeting because it ties every expense to a purpose, preventing ambiguity and overspending.
25,253 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Bilt Rewards rolls out an AI-powered Neighborhood Concierge, enabling renters to pay rent, book amenities, and tap in...
Two space-focused stocks surged on Tuesday as investors parsed earnings and broker calls, lifting AeroVironment and A...
Microsoft led a rebound among the Magnificent 7 as investors rotated back into software, while Apple and Alphabet sli...
BlackRock launches a new staked Ethereum trust on Nasdaq, combining price upside with validator yields. The move mark...
Solana’s stablecoin liquidity reached a new peak in February 2026, while open interest rose to near $6 billion, signa...
Bitcoin hovers around $82,000 as an AI-generated forecast maps multiple year-end paths. The scenarios hinge on ETF de...
Investors aiming for $500 a month in dividend income face a wide capital range, from roughly $85k to over $170k, depe...
NVIDIA and Alphabet reveal divergent AI strategies, highlighting hardware rails versus cloud-powered services, and si...
SpaceX is signaling a public debut that could rewrite IPO benchmarks, even as critics warn the proposed governance st...
As Baozun charts its path in 2026, investors want clarity on revenue growth, margins, and strategic bets. This articl...
Nike faces a pivotal earnings moment as June 30 approaches. This guide breaks down whether you should nike stock befo...